RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

SMILES:

C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O

InChI Key:

XEEQGYMUWCZPDN-UHFFFAOYSA-N

ClinicalTrials.gov PubMed

Clinical Development by Virus5

Human polyomavirus 2

JCV

Target: Human (multiple)

Preclinical

Phase 2

Phase 3

Approved

PMID:19258267

Middle East respiratory syndrome-related coronavirus

MERS-CoV

Target: Human (multiple)

Preclinical

Phase 2

Phase 3

Approved

PMID:24841273

Severe acute respiratory syndrome-related coronavirus

SARS-CoV

Target: Human (multiple)

Preclinical

Phase 2

Phase 3

Approved

PMID:24841273

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2

Target: Human (multiple)

Preclinical

Phase 2

Phase 3

Approved

PMID:32149769

Zika virus

ZIKV

Target: Human (multiple)

Preclinical

Phase 2

Phase 3

Approved

PMID:27889529